APEN logo

Apollo Endosurgery (APEN) Stock

Profile

Full Name:

Apollo Endosurgery, Inc.

Sector:

Healthcare

Country:

United States

IPO:

21 April 2005

Indexes:

Not included

Description:

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for gastrointestinal therapeutic endoscopy. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to suture and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying, which assists the patient in losing weight under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. In addition, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical service providers, hospitals, outpatient surgical centers, clinics, and physicians in the United States, Costa Rica, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

May 03, 2023

Recent annual earnings:

Feb 22, 2022
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Dec 30, 2016

Analyst ratings

Recent major analysts updates

23 Jan '23 Cowen & Co.
Market Perform
04 Jan '23 Stifel
Hold
30 Nov '22 Lake Street
Hold
04 May '22 Stephens & Co.
Overweight
23 Feb '22 Stifel
Buy
15 Dec '21 Cowen & Co.
Outperform
09 Dec '21 Stifel
Buy
09 Sept '21 Stephens & Co.
Overweight
14 June '21 Piper Sandler
Overweight
17 May '21 Lake Street
Buy

Screeners with APEN included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Similar stocks

Weight Loss Services Market Analysis Report 2024-2030, Featuring Profiles of Atkins Nutritionals, Precor, Apollo Endosurgery, Johnson Health Tech, Life Fitness, iFIT, Torque Fitness and More
Weight Loss Services Market Analysis Report 2024-2030, Featuring Profiles of Atkins Nutritionals, Precor, Apollo Endosurgery, Johnson Health Tech, Life Fitness, iFIT, Torque Fitness and More
Weight Loss Services Market Analysis Report 2024-2030, Featuring Profiles of Atkins Nutritionals, Precor, Apollo Endosurgery, Johnson Health Tech, Life Fitness, iFIT, Torque Fitness and More
APEN
globenewswire.com15 October 2024

Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "Weight Loss Services Market Size, Share and Trends Analysis Report by Function (Fitness Equipment, Surgical Equipment, Services), Payment (Out-of-Pocket, Government, Private), and Region 2024-2030" report has been added to ResearchAndMarkets.com's offering. The global weight loss services market size is anticipated to reach USD 60.48 billion by 2030. The market is projected to grow at a CAGR of 7.6% from 2024 to 2030. Rising cases of obesity and resultant health consciousness along with increased per capita healthcare expenditure are the key factors fueling the market growth. Obesity is among the major health concerns that lead to a number of associated diseases or complications, such as diabetes, Cardiovascular Diseases (CVDs), and cancers. For instance, as per WHO, in 2016, more than 1.9 billion adults were overweight, out of which around 650 million people were obese. Such instances are expected to encourage people to maintain proper health to help lower the risk of such chronic health issues, thereby augmenting market growth. Key companies in the market are focusing on the development of new ways for weight loss, such as Zumba, sports-specific performance training, aquatic exercise classes, and weight loss supplements. For instance, in August 2018, Herbalife International launched Herbalife24 ACHIEVE protein bar, a convenient, energy-providing snack. This product launch may increase the company's popularity among athletes worldwide. Hence, such initiatives are anticipated to drive the market. Weight Loss Services Market Report Highlights

FAQ

  • What is the primary business of Apollo Endosurgery?
  • What is the ticker symbol for Apollo Endosurgery?
  • Does Apollo Endosurgery pay dividends?
  • What sector is Apollo Endosurgery in?
  • What industry is Apollo Endosurgery in?
  • What country is Apollo Endosurgery based in?
  • When did Apollo Endosurgery go public?
  • Is Apollo Endosurgery in the S&P 500?
  • Is Apollo Endosurgery in the NASDAQ 100?
  • Is Apollo Endosurgery in the Dow Jones?
  • When was Apollo Endosurgery's last earnings report?
  • When does Apollo Endosurgery report earnings?
  • Should I buy Apollo Endosurgery stock now?

What is the primary business of Apollo Endosurgery?

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for gastrointestinal therapeutic endoscopy. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to suture and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying, which assists the patient in losing weight under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. In addition, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical service providers, hospitals, outpatient surgical centers, clinics, and physicians in the United States, Costa Rica, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

What is the ticker symbol for Apollo Endosurgery?

The ticker symbol for Apollo Endosurgery is NASDAQ:APEN

Does Apollo Endosurgery pay dividends?

No, Apollo Endosurgery does not pay dividends

What sector is Apollo Endosurgery in?

Apollo Endosurgery is in the Healthcare sector

What industry is Apollo Endosurgery in?

Apollo Endosurgery is in the Medical Devices industry

What country is Apollo Endosurgery based in?

Apollo Endosurgery is headquartered in United States

When did Apollo Endosurgery go public?

Apollo Endosurgery's initial public offering (IPO) was on 21 April 2005

Is Apollo Endosurgery in the S&P 500?

No, Apollo Endosurgery is not included in the S&P 500 index

Is Apollo Endosurgery in the NASDAQ 100?

No, Apollo Endosurgery is not included in the NASDAQ 100 index

Is Apollo Endosurgery in the Dow Jones?

No, Apollo Endosurgery is not included in the Dow Jones index

When was Apollo Endosurgery's last earnings report?

Apollo Endosurgery's most recent earnings report was on 3 May 2023

When does Apollo Endosurgery report earnings?

The date for Apollo Endosurgery's next earnings report has not been announced yet

Should I buy Apollo Endosurgery stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions